PRODUCT DETAIL

Ceftazidime Olikla 2 g prášok na injekčný/infúzny roztok

Code

6967E

MA number

15/0187/24-S

Product Form:

plo ijf 50x2 g (liek.inj.skl.)

MA Status:

R - Valid Marketing Authorisation

Type of procedure:

Decentralised

MAH, country:

Olikla s.r.o., Czechia

Therapeutic Class:

15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM)

ATC:

J	ANTIINFECTIVES FOR SYSTEMIC USE
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J01D	OTHER BETA-LACTAM ANTIBACTERIALS
J01DD	Third-generation cephalosporins
J01DD02	Ceftazidime

Shelf life:

Container:

glass vial

Route of admin.:

Intravenous use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	29.07.2024
Validity:	29.07.2029
Pediatric indication:	Yes
Pediatric posology:	Yes
PIL:	PIL_Ceftazidime Olikla 1 g; 2 g prášok na injekčný_infúzny roztok_07_2024.pdf
SPC:	SPC_Ceftazidime Olikla 1 g; 2 g prášok na injekčný_infúzny roztok_07_2024.pdf
Safety feature	Yes
Data update:	30.07.2024